Factors determining the mortality in cirrhosis patients with invasive candidiasis: A systematic review and meta-analysis
Authors:
- 3 November 2021
- journal article
- review article
- Published by Oxford University Press (OUP) in Medical Mycology
- Vol. 60 (1)
Abstract
The impact of invasive candidiasis (IC) on the outcomes in the non-conventional high-risk cirrhosis population is poorly characterized. Therefore, we reviewed the outcomes and their influencing factors in cirrhosis patients with IC. PubMed, Embase, Ovid, CINHAL, and Web of Science were searched for full-text observational studies describing mortality due to IC in cirrhosis. We did a systematic review and random-effects meta-analysis to pool the point-estimate and comparative-odds of mortality. The estimate's heterogeneity was explored on sub-groups, outliers-test, and meta-regression. We evaluated the asymmetry in estimates on funnel plot and Eggers regression. Quality of studies was assessed on the New-Castle Ottawa scale. Of 3143 articles, 13 studies (611 patients) were included (good/fair quality: 6/7). IC patients were sick with a high model for end-stage liver disease (MELD: 27.0) and long hospital stay (33.2 days). The pooled-mortality was 54.7% (95% CI: 41.3--67.5), I2: 80%, P < 0.01. Intensive care unit (ICU) admission (P < 0.001), site of infection; viz. peritonitis and candidemia (P = 0.014) and high MELD of cases (P = 0.029) were predictors of high mortality. The odds of mortality due to IC was 4.4 times higher than controls and was 8.5 and 3.3 times higher than non-infected, and bacterially-infected controls. Studies in ICU-admitted (OR: 5.0) or acute-on-chronic liver failure (ACLF, OR: 6.3) patients had numerically higher odds of mortality than all-hospitalized cirrhosis patients (OR: 4.0). In conclusion, substantially high mortality is reported in cirrhosis patients with IC. ICU admission, ACLF, high MELD, peritonitis, and candidemia are key factors determining high mortality in cirrhosis patients with IC. Lay Summary: We report a high mortality rate of 55% in patients with liver cirrhosis and invasive candidiasis. Higher odds (4.4 times) of death, especially in patients with ACLF (6.3 times) or ICU admission (5.0 times) were seen. Candida peritonitis and candidemia are associated with high mortality in cirrhosis. Highlights:Keywords
This publication has 33 references indexed in Scilit:
- Hepatic Macrophage Activation and the LPS Pathway in Patients With Alcoholic Hepatitis: A Prospective Cohort StudyAmerican Journal of Gastroenterology, 2014
- Epidemiology and outcomes of bloodstream infection in patients with cirrhosisJournal of Hepatology, 2014
- Fungal infection in patients with end-stage liver disease: low frequency or low index of suspicionInternational Journal of Infectious Diseases, 2014
- Invasive Mycosis in Medical Intensive Care Unit Patients with Severe Alcoholic HepatitisMycopathologia, 2014
- Epidemiology and risk factors for invasive candidiasisTherapeutics and Clinical Risk Management, 2014
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analysesEuropean Journal of Epidemiology, 2010
- Outlier and influence diagnostics for meta-analysisResearch Synthesis Methods, 2010
- Detection of Bloodstream Infections in Adults: How Many Blood Cultures Are Needed?Journal of Clinical Microbiology, 2007
- Excess Mortality, Hospital Stay, and Cost Due to Candidemia: A Case-Control Study Using Data From Population-Based Candidemia SurveillanceInfection Control & Hospital Epidemiology, 2005
- Measuring inconsistency in meta-analysesBMJ, 2003